Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness studyElena Moro, Herman Stoevelaar, Michaël Schüpbach et al.|Journal of Neurology|2015Cited by 27
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s diseaseSandra Neumann, Emily J. Henderson, Jodi Taylor et al.|BMC Neurology|2021Cited by 22
Palindrome-mediated 16p13.3 triplications cause a recognizable neurodegenerative disorder with ataxiaJames Fasham, Alistair T. Pagnamenta, Julia Rankin et al.|The American Journal of Human Genetics|2025Cited by 2
Essai VANTAGE : suivi de douze (12) mois d’une étude prospective multicentrique évaluant la stimulation cérébrale profonde avec un nouveau système rechargeable à sources de courant multiples indépendantes (Vercise™) dans la maladie de ParkinsonFrançois Alesch, Lars Timmermann, M. Maarouf et al.|Neurochirurgie|2014Cited by 0